In ALS, there was a pronounced increase in antibody levels against YghJ from day 0 to day 7, with a 267-fold increase for IgA (p = 0.004) and a 55-fold increase for IgG/IgM (p = 0.004) averaged across all volunteers. This evidence concerns the gene CD40LG and amyotrophic lateral sclerosis.